methylphenidate

Neurofeedback or medication to treat ADHD?

by

___

Neu­ro­feed­back (NF) is an approach for treat­ing ADHD in which indi­vid­u­als receive real-time feed­back on their brain­wave activ­i­ty and taught to alter their typ­i­cal EEG pat­tern to one that is con­sis­tent with a more focused and atten­tive state.

While con­sid­er­able research sup­ports the effec­tive­ness of neu­ro­feed­back for many chil­dren with ADHD, rel­a­tive­ly few stud­ies have direct­ly com­pared neu­ro­feed­back to ADHD med­ica­tion. [Read more…] about Neu­ro­feed­back or med­ica­tion to treat ADHD?

Initial study finds promise and limitations in using virtual reality (VR) to treat ADHD

by

___

Giv­en the lim­i­ta­tions of exist­ing evi­dence-based ADHD treat­ments, i.e., stim­u­lant med­ica­tion and behav­ior ther­a­py — research on nov­el inter­ven­tion approach­es con­tin­ues to be important.

Cog­ni­tive train­ing is one such approach that has been sug­gest­ed as a poten­tial adjunct or even replace­ment for med­ica­tion treat­ment. While cog­ni­tive train­ing takes dif­fer­ent forms, e.g., com­put­er­ized atten­tion train­ing, work­ing mem­o­ry train­ing, the basic idea is that by repeat­ed­ly prac­tic­ing cog­ni­tive tasks relat­ed to atten­tion, one’s abil­i­ty to focus and attend will improve. In oth­er words, [Read more…] about Ini­tial study finds promise and lim­i­ta­tions in using vir­tu­al real­i­ty (VR) to treat ADHD

5 Must-Read Articles, and an Online Course, to Help Children with ADHD

by

—–

– Dr. David Rabin­er, Research Pro­fes­sor in the Depart­ment of Psy­chol­o­gy and Neu­ro­science at Duke Uni­ver­sity and founder of the Atten­tion Research Update.

Giv­en the ongo­ing changes and con­tro­ver­sies sur­round­ing ADHD diag­no­sis and treat­ment, let us high­light 5 key arti­cles writ­ten by Duke Uni­ver­si­ty’s Dr. David Rabin­er to sum­ma­rize recent sci­en­tif­ic find­ings and their impli­ca­tions, plus a very rel­e­vant online course to help par­ents and pro­fes­sion­als help chil­dren with ADHD.

1. Study finds large gaps between research and prac­tice in ADHD diag­no­sis and treatment

  • Key insight: Evi­dence-based guide­lines from the Amer­i­can Acad­e­my of Pedi­atrics on the eval­u­a­tion and treat­ment of ADHD are fre­quent­ly not fol­lowed. Many chil­dren are diag­nosed with ADHD in the absence of clear­ly meet­ing DSM diag­nos­tic cri­te­ria, and behav­ioral treat­ment is rarely recommended.
  • Key data point: Pedi­a­tri­cians pre­scribed ADHD med­ica­tion to rough­ly 93% of youth diag­nosed with ADHD. Doc­u­men­ta­tion that behav­ioral treat­ment was rec­om­mend­ed, how­ev­er, was present in only 13% of the charts.

[Read more…] about 5 Must-Read Arti­cles, and an Online Course, to Help Chil­dren with ADHD

Growing awareness of the opportunities and risks posed by pharmacological cognitive enhancement (aka “smart drugs”)

by

Nootropics

.

More research need­ed on use of ‘smart drugs’ by healthy peo­ple (Med­ical News):

“Drugs such as methylphenidate and modafinil, mar­ket­ed as Rital­in and Provig­il respec­tive­ly, are used by some healthy indi­vid­u­als in order to boost their cog­ni­tive per­for­mance, despite a gen­er­al lack of knowl­edge about [Read more…] about Grow­ing aware­ness of the oppor­tu­ni­ties and risks posed by phar­ma­co­log­i­cal cog­ni­tive enhance­ment (aka “smart drugs”)

Study: Use of methylphenidate-based ADHD medication increases the risk of heart problems

by

Methylphenidate_pillsADHD med­ica­tion enhances the risk of heart prob­lems in chil­dren (Sci­ence Nordic):

“The risk of devel­op­ing heart prob­lems is twice as big for chil­dren tak­ing med­i­cine for Atten­tion Deficit-Hyper­ac­tiv­i­ty Dis­or­der (ADHD) when com­pared to chil­dren not receiv­ing the medicine…The study builds on data from 714,000 chil­dren [Read more…] about Study: Use of methylphenidate-based ADHD med­ica­tion increas­es the risk of heart problems

Use and misuse of ADHD drugs and nootropics among teenagers and toddlers

by

Human-brain-pillsRital­in may pose brain risks for young peo­ple with­out ADHD, study shows (Fox News):

“Smart” drugs, like Rital­in, also known as nootrop­ics, are known to increase a person’s atten­tion span, mem­o­ry and abil­i­ty to stay alert. As a result, they have become increas­ing­ly abused by stu­dents seek­ing an extra edge in their stud­ies. Accord­ing to a report from The Part­ner­ship at Drugfree.org and the MetLife Foun­da­tion, approx­i­mate­ly 1.3 mil­lion Amer­i­can teenag­er [Read more…] about Use and mis­use of ADHD drugs and nootrop­ics among teenagers and toddlers